New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks Telling Their Stories Through Posters Survivors and advocates display their posters alongside the work of thousands of cancer researchers. by Kevin McLaughlin Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research. by Kevin McLaughlin FORWARD LOOK Cancer Patients Can Now Defer Student Loans Payments can be put off during treatment and for six months after. by Bradley Jones More Options for Rare Cancers Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options. by Kendall K. Morgan The Patient Perspective Patient-reported outcomes may help shape the future of cancer care. by Stephen Ornes Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor The Education of a Patient Advocate Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling. by Bob Riter Survivor Profile The Bridge Builder Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer. by Marci A. Landsmann next Cancer Talk New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks PARP Inhibitors in Pancreatic Cancer Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer. by Kate Yandell Telling Their Stories Through Posters Survivors and advocates display their posters alongside the work of thousands of cancer researchers. by Kevin McLaughlin The Crowded Field of Checkpoint Inhibitors Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field. by Kate Yandell More Posts